2022 at a glance

2022 milestones

January 2022

Myanmar

LabMyNet project activities in Myanmar build diagnostic capacity for HIV and SARS-CoV-2 viral load surveillance

March 2022

Bangladesh

New prospective study for the diagnosis of paediatric and extra-pulmonary TB starts in Bangladesh

March 2022

Madagascar & Cameroon

APRECIT project steering committee reviews activities to improve management of latent tuberculosis in Madagascar and Cameroon

March 2022

Moldova

First field mission to Moldova to identify needs in the face of the influx of Ukrainian migrants

April 2022

Madagascar

Partners of the project to fight malnutrition in southern Madagascar visit the Nutrisud container plant

April 2022

Burkina Faso

Burkina Faso Emerging and Re-emerging Pathogens Laboratory joins the GABRIEL international scientific network

April 2022

Lebanon

The Mérieux Foundation supports a tuberculosis screening campaign for the Lebanese population

April 2022

Moldova

Official visit to Moldova by Alain Mérieux, President of the Mérieux Foundation, to define a project between the “Toma Ciorba” Infectious Diseases Hospital and the “Nicolas Testemitanu” University of Medicine and Pharmacology

May 2022

Les Pensières Center for Global Health

The ADVAC Advanced Course on Vaccinology goes back to the classroom for its 22nd edition

June 2022

Guinea & Mali

The Mérieux Foundation deploys laboratory leadership training in Guinea and Mali

July 2022

Togo

RESAOLAB members attend technical workshops in Lomé

August 2022

Global

The Mérieux Foundation and the Every Breath Counts coalition announce the winners of the World Pneumonia Day small grants awards

October 2022

Les Pensières Center for Global Health

The goal of promoting the role and value played by medical diagnostics in improving public health was achieved at the 11th edition of the ACDx

November 2022

Republic of Congo

The Congolese Foundation for Medical Research joins the GABRIEL network

November 2022

Les Pensières Center for Global Health

The 3rd edition of the AMR course defends the values of the OneHealth approach to fighting antimicrobial resistance

November 2022

Laos

The BoliLab project final appraisal presents the results of its work to reinforce laboratories’ diagnostic capacities

November 2022

Senegal

The second Afro-ACDx course brings together people involved in diagnosis in Africa to discuss leadership issues

December 2022

Senegal

End of the Fellowship Scheme for improving expertise in AMR in Senegal

December 2022

Southeast Asia

The 2022 edition of the Mekong Hepatitis Symposium highlights the advances and current challenges in the fight against hepatitis

December 2022

Madagascar

The Mérieux Foundation publishes the results of lessons learned from experience with RESAMAD

2022 at a glance

Emergency support for Moldova

Covering an area of less than 13,000 square miles between Ukraine and Romania, Moldova is on the frontline of the Ukrainian refugee crisis. In 2022, the Mérieux Foundation decided to support a two-pronged intervention: immediate back-up, followed by structural support for the healthcare reforms undertaken by the Moldovan Ministry of Health.

Since the start of the Russian invasion of Ukraine, many Ukrainians fleeing the conflict have sought shelter in neighboring Moldova, as an intermediate step before moving on to a European Union country. Such an influx of refugees, today making up 16% of the country’s total population, is exerting considerable strain on the Moldovan healthcare system. Although the first wave of arrivals was mainly made up of individuals able to manage their own journey, subsequent waves have seen an increasing number of individuals needing healthcare before continuing their journey. This presents a real challenge for the Moldovan government.

Following the first exploratory mission in March 2022 during which the Foundation met the key parties involved in the healthcare system, several needs were identified:

  • Immediate humanitarian needs, such as the refurbishment of a refugee reception center or the supply of IV bags for hospitals.
  • The need to support laboratories so that they can absorb the requirements created by the influx of refugees and, over a longer-term period and as part of the implementation of healthcare system reforms, to support the reform of the laboratory system. To this end, the Foundation is assisting the Ministry of Health by focusing on renovating the laboratory at the main hospital for infectious diseases and ensuring its integration into the university hospital system, and by strengthening the laboratory system.

Moldova in the Ukraine crisis

  • A landlocked country covering 12,741 square miles between Romania and Ukraine
  • 2.6 million inhabitants, lowest GDP per capita in Europe
  • Over 300,000 Ukrainians have sought refuge in Moldova since the start of the war: 200,000 continued their journey west to Europe and over 100,000 stayed in the country

Providing emergency humanitarian aid

Emergency medical aid – March 2022

In order to assist the Ministry of Health in providing healthcare to refugee populations, the Foundation participated in two emergency operations:

  • Support for the humanitarian convoy of the NGO Pharmacie Humanitaire Internationale to transport medical equipment to the Republican Hospital of Chisinau (oxygen therapy equipment and ventilators, generators) and to the Carpineni refugee reception center (hygiene and baby food products, and medicines).
  • Supply of IV bags (16,000 bags purchased in partnership with Pharmacie Humanitaire Internationale) at the request of the Moldovan Ministry of Health​.
    The transport costs were covered by the Auvergne-Rhône-Alpes Region.

Support for the Carpineni reception center for Ukrainian refugees – April 2022

The Mérieux Foundation funded the installation of shower facilities in the Carpineni refugee reception center, located around 60 miles south of the Moldovan capital of Chisinau. With a capacity to accommodate 180 individuals, the building has mainly housed women and children since the start of the conflict but did not have any showers or hot water. The work, which was completed in April, resulted in the installation of six shower rooms and the purchase of equipment to access hot water, in order to house the refugee population in acceptable sanitary conditions.

Financial support for the Dacia association – December 2022

The Foundation provided financial aid to the NGO Dacia, which has been strongly committed to housing refugees since the start of the war in Ukraine. This support was granted to ensure the running of the association over the winter period. The increase in the price of gas would have forced Dacia to close its doors to the public, as it was unable to pay the heating bills for the building. Over 400 people benefit from the association’s support.

Strengthening the laboratory system

Support for the Moldovan Ministry of Health in strengthening the national laboratory system was developed in two stages:

  • The reinforcement of a key laboratory in order to upgrade the technical facilities and improve the capabilities and quality of biological diagnosis, in particular with regard to the needs and risks linked to the refugee crisis.
  • The provision of technical assistance in terms of laboratories to the Ministry of Health as part of reforms to the Moldovan healthcare system.

Refurbishment of a microbiology laboratory – work beginning in 2023

The refurbishment of the microbiology laboratory at the Toma Ciorba Hospital for Infectious Diseases was the first step in meeting the need to improve the quality of diagnosis and to take on a greater volume of analyses. This new facility will also provide students at the Nicolae Testemitanu University of Medicine and Pharmacy with a modern training and research platform in clinical microbiology. The Foundation is providing its expertise as an assistant to the contracting authority for the design and monitoring of refurbishment work on the building that will house the laboratory. It is also providing the equipment for the facility and taking care of staff training with the aim of obtaining the ISO 15189 international accreditation that applies to medical biology laboratories.

Technical support to reform the laboratory system

In accordance with the need expressed by the Moldovan Minister of Health, Ala Nemerenco, the Mérieux Foundation will provide support to reform the laboratory system, identified by local experts as the weak link in the Moldovan healthcare system. Through this intervention, the Foundation will assist local parties concerned to gain a better perspective and understanding of other systems and the different potential organizational scenarios. This will make it possible to select the most suitable option and to optimize the laboratory service offering to meet the needs of the population and public health, while guaranteeing an optimal level of quality, biosafety and biosecurity. Particular attention will be paid to certain aspects brought to the attention of the Foundation’s teams, such as the referencing system and antimicrobial resistance.

Meeting the country’s needs

  • March 2022: joint mission between the Mérieux Foundation and PHI (Pharmacie Humanitaire Internationale — International Humanitarian Pharmacy)
  • April 2022: assessment mission to identify the needs of the country’s laboratories
  • April 2022: official visit of the Mérieux Foundation’s President
  • June 2022: mission to prepare the joint laboratory project between the Toma Ciorba Hospital for Infectious Diseases and the Nicolas Testemitanu University of Medicine and Pharmacy
  • September 2022: mission of the Foundation’s Senior Management to validate the project with the authorities

2022 at a glance

Governance 2022

Board of Directors

Representatives of the founding members

Alain MÉRIEUX . President

Chantal MÉRIEUX . Karine MEHLER . Olivia MÉRIEUX . Alexandre MÉRIEUX

Qualified Persons

Didier CHERPITEL . Prof. Jean-François DELFRAISSY . Prof. David L. HEYMANN . Dr. Marie-Paule KIENY . Prof. Didier RAOULT . Dr. Robert SEBBAG . Bernard SINOU

Government Representative

The Prefect of the Auvergne-Rhône-Alpes Region

Management committee

  • Jean-Pierre BOSSER
    Director General
  • Dr. Marc BONNEVILLE*
    Medical & Scientific Director / Deputy Director General*Until December 31, 2022
  • Dr Phillipe VANHEMS*
    Medical & Scientific Director*Acting since January 1, 2023
  • Clélia LEBAYLE
    Secretary General / Director of Support Functions
  • Dr. François-Xavier BABIN
    Director of International Operations
  • Dr. Pascal VINCELOT*
    Director of Cooperation and Prospective Programs
    *Until March 31, 2023
  • Bénédicte PANSIER
    Director of Les Pensières Center for Global Health

Scientific Advisory Board

  • Dr. Marie-Paule KIENY
    Présidente, Inserm (France)
  • Dr. Valérie D’ACREMONT
    Swiss Tropical and Public Health Institute (Switzerland)
  • Prof. Abdullah BROOKS
    Johns Hopkins Bloomberg School of Public Health, Baltimore (United States)
  • Dr. Kevin DE COCK
    CDC (Centers for Disease Control and Prevention) (Kenya)
  • Prof. Hubert ENDTZ
    Erasmus University Rotterdam (Netherlands)
  • Dr. Rana HAJJEH
    WHO/Regional Office for the Eastern Mediterranean (Egypt)
  • Prof. Francine NTOUMI
    Congolese Foundation for Medical Research (Congo)
  • Prof. Jean-William PAPE
    GHESKIO centers (Haiti)
  • Dr. Firdausi QADRI
    International Centre for Diarrhoeal Disease and Research (Bangladesh)
  • Dr. Voahangy RASOLOFO
    Institut Pasteur Madagascar (Madagascar)
  • Dr. Wenhong ZHANG
    Huashan Hospital of the Fudan University (China)

*Until August 26, 2021

Mérieux Foundation USA

Board of Directors

  • Pr David L. HEYMANN
    Preésident, London School of Hygiene & Tropical Medicine (UK)
  • Dr Jon ANDRUS
    Center for Global Health, University of Colorado; Department of Global Health, Milken Institute of Public Health, George Washington University (USA)
  • Didier CHERPITEL
    Mérieux Foundation Board of Directors (France)
  • Dr Kevin DE COCK
    CDC (Centers for Disease Control and Prevention) (Kenya)
  • Dr Warren JOHNSON
    Center for Global Health, Weill Cornell Medical College (USA)
  • Karine MEHLER
    Mérieux Foundation Board of Directors (France)
  • Clare O’BRIEN
    Shearman & Sterling (USA)

Management committee

  • Koren WOLMAN-TARDY
    Chief Executive Officer
  • Aline FRIMON-RICHARD
    Director of Finance & Operations
  • Allegra MOLKENTHIN
    Program & Operations Officer

2022 at a glance

Financial partners 2022

To successfully carry out its development projects in LMICs and ensure they produce sustainable results, the Mérieux Foundation brings together national and international public and private partners with local organizations. The trust and commitment of its new or long-standing partners have made it possible for the Foundation to help local stakeholders in their fight against infectious diseases. The Mérieux Foundation thanks them warmly for their support.

Regional, national & international institutions

  • Agence Française de Développement (AFD)
  • Coalition for Epidemic Preparedness Innovations (CEPI)
  • Defense Threat Reduction Agency (DTRA)
  • Department of Foreign Affairs and Trade, Australian Government (DFAT)
  • Department of International Cooperation of Prince’s Government of Monaco
  • Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ)
  • European Commission
  • Expertise France
  • Fleming Fund : UK Department of Health and Social Care via Mott McDonald
  • Global Fund via UMRSS (Unité de mise en œuvre du renforcement du système de santé) – Mali
  • Horizon 2020 (European Commission)
  • IFPMA (International Federation of Pharmaceutical Manufacturers and Associations)
  • Infectious Disease Detection and Surveillance (IDDS-USAID)
  • International Development Association (IDA) via WAHO
  • International Organization for Migration (IOM)
  • L’Initiative (Expertise France)
  • Luxembourg Government Aid and Development Agency (LuxDev)
  • Région Auvergne-Rhône-Alpes
  • Swedish International Development Cooperation Agency (Sida)
  • The Joint Programming Initiative on Antimicrobial Resistance (JPIAMR)
  • US Centers for Disease Control and Prevention (CDC)
  • UK Foreign Commonwealth Development Office (FCDO)
  • United States Agency for International Development (USAID)
  • World Health Organization (WHO)

Foundations & NGOs

  • Bill & Melinda Gates Foundation
  • Chinese Red Cross
  • Fondation AnBer
  • Fondation Christophe et Rodolphe Mérieux
  • Fondation Pierre Fabre
  • Fondation Raoul Follereau
  • Fondation Saint-Irénée
  • French Red Cross
  • Global Alliance for Rabies Control (GARC)
  • IPHARMEX
  • The Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund)

Universities & research institutes

  • ANRS | Emerging Infectious Diseases
  • French National Research Agency (ANR)
  • Institut de Recherche pour le Développement (the French National Research Institute for Sustainable Development)
  • Oxford University
  • University of Geneva

Industry & companies

  • bioMérieux
  • Cepheid
  • CNine
  • GlaxoSmithKline Biologicals (GSK)
  • Illumina
  • Institut Mérieux
  • Janssen Vaccines & Prevention (JNJ)
  • Merck/MSD
  • Pfizer
  • Roche
  • Sanofi Pasteur
  • Serum Institute of India
  • Shearman & Sterling
  • Société MBD
  • Takeda

2022 at a glance

Accounts and key figures 2022

Balance sheet

Assets
(K€)
Net
December 31, 2022
Net
December 31, 2021
Fixed assets
Intangible fixed assets 875 1,158
Property, plant and equipment 4,396 4,536
Investments and other financial assets 45,436 38,541
Total 50,706 44,235
Current assets
Accounts receivable 909 952
Other receivables 13,302 17,560
Marketable securities 38,600 38,600
Cash and cash equivalents 16,616 22,441
Prepaid expenses 2,202 4,591
Unrealized exchange losses 6 2
Total 71,635 84,146
Total Assets 122,341 128,381
Liabilities and fund balance
(K€)
December 31, 2022 December 31, 2021
Fund balance
True endowment 68,216 68,216
Reserves 884 884
Retained earnings 15,437 9,003
Net income / loss for the period 203 6,433
Other endowment 7 7
Total 84,747 84,544
Quasi endowment
Allowence for contigencies 117 238
Funds reserved for future engagements 2,200 3,961
Total 2,318 4,199
Liabilities
Loans 5,438 5,010
Accounts payable 3,270 1,541
Tax and social debts 1,704 1,719
Investment payable 228
Other payable 5,502 4,318
Deferred income 19,361 26,819
Unrealized exchange gains 2 3
Total 35,276 39,638
Liabilities and fund balance 122,341 128,381

Income statement

(K€) Actual 2022 Actual 2021
Income
Services revenue 957 165
Income from third-party funders 20,310 16,905
Expenses refund 179 1,073
Other operating income 135 87
Total income 20,292 21,635
Expenses
External purchases and expenses 14,214 13,240
Financial aid 4,348 3,869
Taxes and duties 891 765
Salaries and social contributions 6,718 5,749
Depreciations 760 719
Dedicated funds carried over -1,760 316
Other operating income 263 102
Total expenses 25,433 24,760
Operating results -5,140 -3,124
Financial income
Dividends 884 911
Other financial income 5,210 3,687
Reverse on financial allowances 52 324
Net income from marketable securities 5,000
Total financial income 6,147 9,922
Financial expenses
Financial allowances 227 170
Other financial expenses 537 118
Total financial expenses 764 288
Financial results 5,383 9,634
Exceptional income
Exceptional income 44
Exceptional reverse in allowances 97
Total exceptional income 97 44
Exceptional costs
Exceptional expenses 137 2
Exceptional allowances for contingencies 117
Total exceptional costs 137 120
Exceptional result -40 -76
Income tax
Total income 26,536 31,601
Total expenses 26,333 25,168
Intermediate balance 203 6,433

Breakdown of expenses

Excluding provisions and exceptional expenses

Missions 74%
Administration 20%
International support 6%

Geographical segmentation of activities

Africa 30%
Asia 22%
Europe(1) 28%
Madagascar 9%
Middle East 5%
Haiti 5%
South America 2%

(1)Activities carried out by teams based in Europe, in or for the other countries (including coordination)

Breakdown of expenses by strategic area of focus

Excluding provisions and exceptional expenses

Diagnostics – Health systems 70%
Applied research 14%
Mother & child programs 9%
Knowledge sharing 6%

Breakdown of income

Excluding dedicated funds, provisions and non-recurring items

Financial products & real estate income 20%
Public partnerships 29%
Sponsorship 26%
Other private partnerships 24%
Fondation Christophe et Rodolphe Mérieux 1%
Donations & legacies 0

Changes in headcount* as at December 31, 2022

159 employees worldwide**
*Full-time equivalents
**Excluding interns, temporary employees

Dowload the statutory auditor’s report on the financial statements
For the year ending December 31, 2022

Evolution of expenses by strategic area of focus

In K€, excluding depreciation, provisions, financial expenses and future engagements